OATP1B3 KNOCKOUT HEPARG CELLS

Code: MTOX1016-1VL D2-231

Application

See technical bulletin for detailed protocols

Features and Benefits

Zinc finger nucleases (ZFN) mediated Knock-out of SLCO1B3 (MRP3) ...


read more

Your Price
€1,653.60 EACH
€2,033.93 inc. VAT

Application

See technical bulletin for detailed protocols

Features and Benefits

Zinc finger nucleases (ZFN) mediated Knock-out of SLCO1B3 (MRP3) gene. The frame-shift mutation of SLCO1B3 gene was confirmed by fragment length analysis and DNA sequencing. Loss of functionality was confirmed by loss of transport of selective substrates in sandwich culture assay.

General description

HepaRG is a human hepatoma cell line. The cells possess a pseudodiploid karyotype and have been characterized as an oval ductular bipotent hepatic cell line as they have the ability to differentiate into both biliary and hepatocyte lineages in the presence of DMSO. HepaRG OATP1B3 knockout cells express the major xenobiotic sensors (PXR, CAR and AhR), drug transporters, phase I and II drug metabolizing enzymes as well as key hepatic transcription factors involved in stress response pathways.

Legal Information

HepaRG is a trademark of BioPredic International company

These products are covered by the License Agreement as described in Exhibit 1, 2 and 3, in the technical bulletin.

Quality

Tested for Mycoplasma, sterility, post-freeze viability, short terminal repeat (STR) analysis for cell line identification, cytochrome oxidase I (COI) analysis for cell line species confirmation.

biological sourcehuman female liver (hepatocarcinoma and hepatitis C tumor)
formliquid
Gene Informationhuman ... OATP1B3(28234)
OMIM accession no.605495
Quality Level200
storage temp.−196°C
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.